Lightbridge Corp reports Q2 2026 earnings on August 5, with consensus expecting zero revenue and no formal EPS estimate, as shares trade at $8.70 with no active analyst price target. The key story investors are watching is the progress of Lightbridge Fuel™ irradiation testing and the company's HALEU supply chain strategy.
Recent developments include an MOU with Quadrant Nuclear Industries to secure domestic fuel supply and successful milestone testing at the Idaho National Laboratory. With $215.7 million in cash as of Q1, the company maintains a multi-year runway to fund its capital-intensive R&D and NRC licensing pathways.